FAQ Library
Dr. Neil Shah discusses the efficacy and safety considerations of imatinib therapy.
Dr. Jorge Cortes discusses the sensitivities of different CML therapies to various mutations including the T315I mutation.
Dr. Susan O'Brien discusses what the standard workup for a newly diagnosed CML patient should include.